HF-GRO Will Fund Pre-Clinical Research in Aging Biology and Geroscience
RIYADH, Saudi Arabia-
Hevolution Foundation, a non-profit organization that provides grants and early-stage investments to incentivize research and entrepreneurship in healthspan science, is launching a new grants program, “Hevolution Foundation – Geroscience Research Opportunities” (HF-GRO). HF-GRO will provide funding for pre-clinical research in aging biology and geroscience in the United States, Canada, and Europe. The program has a budget of up to $25 million for the remainder of 2023, and up to $115 million over five years.
“We see HF-GRO as a major step on the path to funding a significant amount of promising aging biology and geroscience research on an international scale,” commented Felipe Sierra, PhD, Hevolution Foundation’s Chief Scientific Officer. “We anticipate releasing calls covering other geographic areas in the coming months.”
Funded projects are expected to last four to five years, with direct costs of each project anticipated to be in the range of $300,000 to $500,000 annually. The HF-GRO Awards are for basic and translational research only (not clinical trials).
The American Federation for Aging Research (AFAR) is providing programmatic support for the HF-GRO program for Hevolution Foundation.